Authors



Ryan Gray, MD

Latest:

The 10 Worst Things Patients Can Say to Physicians

Most patients are well-meaning and generally nice. But every now and then, you will get one who is a total pain to deal with. Maybe your patient lies to you, gets sarcastic, asks for special “favors,†or generally just pushes your buttons. We’ve all been there.




Kelly C. Rogers, PharmD

Latest:

Procainamide-induced Pleural and Pericardial Effusions

Drug-induced diseases and serious adverse drug effects can alter therapeutic plans and greatly affect patient outcomes. Many medications are known to have a narrow therapeutic index and to require close patient monitoring.


Don S. Dizon MD

Latest:

Treating Breast Cancer in Pregnancy Affords a Survival Advantage

An abstract presented at 2010 Breast Cancer Symposium analyzed pregnant women with breast cancer.


Cristina Fernández, MD

Latest:

Antiplatelet and anticoagulant therapy in patients with atrial fibrillation

We investigated 1209 patients with valvular and nonvalvular atrial fibrillation who were treated with standard anticoagulant therapy, the cyclooxygenase inhibitor triflusal, or combined therapy with triflusal and an anticoagulant. Compared with patients receiving standard anticoagulation treatment, the addition of antiplatelet therapy to reduced-intensity anticoagulation in patients stratified for risk of stroke significantly reduced the vascular event rate.


Brittany Roshelle Davis

Latest:

Executive Function Disorder and ADHD

Executive function disorder and ADHD share several overlapping symptoms, and the presence of executive function impairment is often associated with a diagnosis of ADHD. Clinicians should be aware of the testing modalities that can help accurately identify executive function disorder, and also be aware of the limitations of current medications when it comes to mitigating symptoms.


Beth McLellan, MD

Latest:

6 Ways Oncologists and Dermatologists Can Work Together to Improve Cancer Care

Collaboration between dermatologists and oncologists is crucial.


Stephan von Bardeleben, MD

Latest:

Analysis of regional left ventricular function

We performed cineventriculography, unenhanced echocardiography, contrast-enhanced echocardiography, and magnetic resonance imaging to define the presence of regional left ventricular wall motion abnormalities. Interobserver agreement in the analysis of regional wall motion abnormality was highest for contrast-enhanced echocardiography, followed by cineventriculography and cardiac magnetic resonance imaging; it was lowest for unenhanced echocardiography. Contrast-enhanced echocardiography also showed the highest accuracy in the detection of panel-defined regional wall motion abnormalities.


Erica Slaughter, MSc

Latest:

Considerations for Duration of DAPT in Patients With Diabetes

The optimal duration of dual antiplatelet therapy remains unclear, despite being proven efficacious for roughly 2 decades.


Srulik Dvorsky, BSc

Latest:

The "Team" Behind Docs That Helps Deliver the Best Results

AI tools and health tech can be used to help the healthcare system treat patients.



Jaya V. Juturi, MD

Latest:

Do You Have the Right Tools?: How IT adoption can enhance your practice

True integration of cutting-edge care and timely translation of information from the bench to bedside requires an oncology practice to have knowledgeable physicians and a "toolbox of technology."


Nicholas Avgerinos, MD

Latest:

Could Saturated Fat Be Good for the Heart?

Current dietary guidelines promoting high consumption of polyunsaturated fatty acids and low consumption of total saturated fats are not clearly supported by the medical literature.


Barbara J. Lennert, RN, BSN, MAOM

Latest:

NOW Initiative: Payer & Provider Collaborations in Oncology Benefits Management

Payers recognize the need to expand benefits management for oncology but struggle to find effective solutions amid the complexity of available therapies and skepticism from oncologists, who are facing their own set of economic pressures. The National Oncology Working Group (NOW) Initiative is trying to change the sometimes adversarial relationship between payers and oncologists through a collaborative model.


MD Magazine&reg Editorial Staff

Latest:

ARO-HBV Reduces All Measurable Viral Products in Patients with Chronic Hepatitis B Virus Infection

The first results of a study on the use of monthly RNAi with ARO-HBV in patients with chronic hepatitis B virus infections indicate that the treatment effectively reduced all measurable viral products, including HBsAg.






Chris Paton, BMBS, BMedSci

Latest:

Useless Medical Devices

Throughout history, the public's pursuit of good health has, in the absence of scientific method or even common sense, motivated the creation of some downright ridiculous medical devices.


Anette Hanson, MD

Latest:

Can I Hit Back?

Will a doctor get into trouble for defending him or herself?


William Ntim, MD: From Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina.

Latest:

Chest pain syndrome in women: A diagnostic dilemma

The ability to diagnose coronary artery disease (CAD) in women may be limited by the sensitivity and specificity of symptoms as well as of noninvasive testing. The choice of which test should be performed to evaluate the presence of CAD in women remains controversial. Currently American Heart Association/American College of Cardiology guidelines recommend initial evaluation with exercise electrocardiogram (ECG) testing. In a meta-analysis of 3721 women, however, exercise ECG had a sensitivity of 61% and a specificity of 70%1 as compared to 68% sensitivity and 77% specificity in men.




Fiona Ecarnot, MSc

Latest:

Renal dysfunction in older age groups and mortality after acute myocardial infarction

Only one third of patients admitted to the hospital with acute myocardial infarction have normal renal function, and 17% have severe renal impairment. Decreased renal function is associated with the presence of comorbid conditions, underuse of effective treatments, and higher mortality. Renal function parameters should not only be included in scoring systems to assess risk levels, but patients with abnormal renal function should benefit from careful application of guidelines-recommended treatments for acute and long-term care.


Brian G. Feagan, MD, FACG

Latest:

How to Pick & Choose: Which Patient & Agent in Biologic-Naive Patients

The past decade has seen increased use of TNF antagonists for the treatment of inflammatory bowel disease.



Michael R. Page, PharmD, RPh

Latest:

Reactivation of Hepatitis B Associated With Immunosuppressive Medications

In patients with chronic HBV, the immune system may have very low levels of the virus. When reactivation occurs due to immunosuppression, these viruses begin to replicate again. Common symptoms of this event include inflammation of the liver and elevations of liver enzyme levels in the blood. In some cases, bilirubin levels may rise in response to reactivation of infection.

© 2024 MJH Life Sciences

All rights reserved.